Key Record Dates
ClinicalTrials.gov Identifier: | NCT03591510 |
---|---|
Brief Title: | A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML |
First Submitted : | June 25, 2018 |
First Submitted that Met QC Criteria : | July 7, 2018 |
First Posted : | July 19, 2018 |
Last Update Submitted that Met QC Criteria : | April 4, 2024 |
Last Update Posted : | April 5, 2024 |